ArticleArthroplasty today2026
Unlocking Value: A Cost-Effectiveness Analysis of Hip PJI Diagnostic Pathways Employing the European Bone and Joint Infection Society/Musculoskeletal Infection Society Definition.
Article in Arthroplasty today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The European Bone and Joint Infection Society (EBJIS)/Musculoskeletal Infection Society (MSIS) criteria provide a framework for diagnosing hip periprosthetic joint infection, yet daily clinical application lacks a standardized algorithm. Since these criteria rely heavily on synovial fluid markers, surgeons encounter 2 primary dilemmas: the reliability of aspiration techniques (ultrasound vs fluoroscopy) and the economic trade-off between higher-cost proprietary assays and standard institutional laboratories. This cost-effectiveness analysis was conducted to identify the diagnostic pathway that maximizes clinical benefit while minimizing expenditure within the EBJIS/MSIS framework. Methods: A decision tree model simulated the diagnostic workup of a 67-year-old patient with suspected hip periprosthetic joint infection. Ten strategies were evaluated, comparing aspiration modality and laboratory method (institutional, point-of-care, and third-party analysis). The model incorporated 1- and 2-stage revision pathways and included dry tap scenarios. Accuracy inputs were derived from the literature, and costs reflected 2025 Medicare schedules. Sensitivity analyses tested robustness across diagnostic outcomes. Effectiveness was measured in quality-adjusted life years based on downstream surgical outcomes. Results: Ultrasound-guided aspiration with third-party synovial analysis was most cost-effective in both revision scenarios. Despite higher upfront costs of specialized testing, its superior sensitivity and specificity maximized quality-adjusted life years by reducing morbidity from misdiagnosis. Institutional testing was preferred only if sensitivity exceeded 90% and specificity 94%. In "dry tap" cases, intraoperative lateral flow alpha-defensin testing was favored over preoperative nuclear imaging. Surgical outcome utility most strongly influenced the results. Conclusions: Within the EBJIS/MSIS framework, prioritizing high-accuracy diagnostic tools maximizes value by reducing misaligned revision strategies. Diagnostic precision outweighed individual test cost in determining cost-effectiveness. Level of Evidence: Economic and decision analysis, Level II.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.